Skip to content

SNDA submitted to FDA for venetoclax, acalabrutinib combo in CLL
SOHO EAGLE program takes off, expanding access to education globally
Dr. Shulman discusses US cancer surveillance challenges
New blood test diagnoses multiple myeloma noninvasively
Treatment post-relapse improves survival outcomes in patients with AML or MDS

Join SOHO

Follow Us :

Insider Podcast
About
Society Updates
- Society Updates
- Join SOHO
Resources
Hem/Onc Library
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Meeting News
Multimedia
- Roundtable Discussions
  - MDS Roundtable
  - MPN Roundtable
- Video Interviews
Subscribe

About Us

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Join SOHO

Categories

Guillermo Garcia-Manero, MD

Cellular Therapy

Guillermo Garcia-Manero, MD

Leukemia

Guillermo Garcia-Manero, MD

Lymphoma

Guillermo Garcia-Manero, MD

Multiple Myeloma

Guillermo Garcia-Manero, MD

Myelodysplastic Syndromes

Guillermo Garcia-Manero, MD

Myeloproliferative Neoplasms

Contact Info

[email protected] 1.281.364.7387

Follow Us

August 19, 2025

Insider Podcast
About
Society Updates
- Society Updates
- Join SOHO
Resources
Hem/Onc Library
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Meeting News
Multimedia
- Roundtable Discussions
  - MDS Roundtable
  - MPN Roundtable
- Video Interviews
Subscribe

SOHO Insider Guillermo Garcia-Manero, MD

Guillermo Garcia-Manero, MD

by sohonews
October 16, 2024
0 Comments
Less than a minute
189 Views
10 months ago

Share This Post:

Facebook Twitter Pinterest Whatsapp Cloud StumbleUpon Print Share via Email

Related Post

Submit

News

SNDA submitted to FDA for venetoclax, acalabrutinib combo in

August 16, 2025

Society Updates

SOHO EAGLE program takes off, expanding access to education

August 14, 2025

Multiple Myeloma

Dr. Shulman discusses US cancer surveillance challenges

August 14, 2025

Multiple Myeloma

New blood test diagnoses multiple myeloma noninvasively

August 13, 2025

a globe

Acute Myeloid Leukemia, Myelodysplastic Syndromes

Treatment post-relapse improves survival outcomes in patients with AML

August 11, 2025

hand of a lab technician holding blood tube test and background a rack of color tubes with blood samples other patients / laboratory technician holding a blood tube test

Multiple Myeloma

BELLINI trial does not show overall survival benefit for

August 10, 2025

Top Categories

Cellular Therapy

13

Leukemia

44

Lymphoma

50

Multiple Myeloma

42

Myelodysplastic Syndromes

16

Myeloproliferative Neoplasms

11

POPULAR NEWS

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Categories

Guillermo Garcia-Manero, MD

Cellular Therapy

Guillermo Garcia-Manero, MD

Leukemia

Guillermo Garcia-Manero, MD

Lymphoma

Guillermo Garcia-Manero, MD

Multiple Myeloma

Guillermo Garcia-Manero, MD

Myelodysplastic Syndromes

Guillermo Garcia-Manero, MD

Myeloproliferative Neoplasms

Subscribe

Recent Posts

Submit

SNDA submitted to FDA for venetoclax, acalabrutinib combo in CLL

SOHO EAGLE program takes off, expanding access to education globally

Dr. Shulman discusses US cancer surveillance challenges

Copyright © 2025 Society of Hematologic Oncology, All rights reserved.